Centessa Pharmaceuticals PLC CNTA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EDT
9.25UNCH (UNCH)
Volume
2,205
Close
9.25quote price arrow down-0.22 (-2.32%)
Volume
72,034
52 week range
3.96 - 12.45
Loading...
  • Open9.47
  • Day High9.50
  • Day Low9.24
  • Prev Close9.47
  • 52 Week High12.45
  • 52 Week High Date03/22/24
  • 52 Week Low3.96
  • 52 Week Low Date05/25/23

Key Stats

  • Market Cap1.042B
  • Shares Out112.70M
  • 10 Day Average Volume0.41M
  • Dividend-
  • Dividend Yield-
  • Beta1.45
  • YTD % Change16.21

KEY STATS

  • Open9.47
  • Day High9.50
  • Day Low9.24
  • Prev Close9.47
  • 52 Week High12.45
  • 52 Week High Date03/22/24
  • 52 Week Low3.96
  • 52 Week Low Date05/25/23
  • Market Cap1.042B
  • Shares Out112.70M
  • 10 Day Average Volume0.41M
  • Dividend-
  • Dividend Yield-
  • Beta1.45
  • YTD % Change16.21

RATIOS/PROFITABILITY

  • EPS (TTM)-1.57
  • P/E (TTM)-5.89
  • Fwd P/E (NTM)-5.03
  • EBITDA (TTM)-170.473M
  • ROE (TTM)-52.79%
  • Revenue (TTM)6.853M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-2,204.66%
  • Debt To Equity (MRQ)32.04%

EVENTS

  • Earnings Date05/14/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Centessa Pharmaceuticals PLC

 

Profile

MORE
Centessa Pharmaceuticals plc is a clinical-stage pharmaceutical company. The Company's advanced product candidate, SerpinPC, is a subcutaneously administered inhibitor of activated protein C (APC) being developed as a potential treatment for hemophilia. Leveraging its LockBody technology, it is developing an approach to selectively drive potent effector function activity, such as CD47 or CD3, into the tumor microenvironment (TME) while avoiding systemic toxicity. Its first...
Francesco de Rubertis Ph.D.
Independent Chairman of the Board
Saurabh Saha M.D., Ph.D
Chief Executive Officer, Director
Gregory Weinhoff M.D.
Chief Financial Officer
Antoine Yver M.D.
Executive Vice President and Chairman of Development
Address
3Rd Floor, 1 Ashley Road
Altrincham
WA14 2DT
United Kingdom

Top Peers

SYMBOLLASTCHG%CHG
CGEM
Cullinan Therapeutics Inc
28.40+0.05+0.18%
LQDA
Liquidia Corp
12.69-0.10-0.78%
SAVA
Cassava Sciences Inc
21.52-0.53-2.40%
CATX
Perspective Therapeutics Inc
1.83+0.02+1.10%
BLTE
Belite Bio Inc
43.30+0.10+0.23%